四川精神卫生
四川精神衛生
사천정신위생
Sichuan Mental Health
2015年
5期
407-410
,共4页
周海平%钟远惠%何晓华%徐炳聪
週海平%鐘遠惠%何曉華%徐炳聰
주해평%종원혜%하효화%서병총
氟伏沙明%思维阻断疗法%强迫症
氟伏沙明%思維阻斷療法%彊迫癥
불복사명%사유조단요법%강박증
Fluvoxamine%Thought prevention therapy%Obsessive compulsive disorder
目的:探讨氟伏沙明联合思维阻断疗法对强迫症的疗效。方法采用随机数字表法将56例存在强迫性思维并符合《国际疾病分类(第10版)》(ICD -10)诊断标准的强迫症患者分为氟伏沙明单一治疗组和氟伏沙明联合思维阻断疗法治疗组,观察12周。于治疗前、治疗第4、8、12周末采用耶鲁布朗强迫症状量表(Y - BOCS)进行评定,并采用生活质量综合评定问卷(GQOLI -74)评估治疗前后的生活质量。结果治疗前两组 Y - BOCS 和GQOLI -74评分差异无统计学意义(P >0.05),治疗4周后两组 Y - BOCS 评分较治疗前低,差异有统计学意义(P<0.05),治疗8周后联合组评分较对照组降低更明显,差异有统计学意义(P <0.05);治疗12周后,联合组 GQOLI-74心理功能和社会功能评分高于对照组(P <0.05)。结论氟伏沙明联合思维阻断疗法治疗有强迫性思维的强迫症患者较单用氟伏沙明疗效更好,并能改善患者的生活质量。
目的:探討氟伏沙明聯閤思維阻斷療法對彊迫癥的療效。方法採用隨機數字錶法將56例存在彊迫性思維併符閤《國際疾病分類(第10版)》(ICD -10)診斷標準的彊迫癥患者分為氟伏沙明單一治療組和氟伏沙明聯閤思維阻斷療法治療組,觀察12週。于治療前、治療第4、8、12週末採用耶魯佈朗彊迫癥狀量錶(Y - BOCS)進行評定,併採用生活質量綜閤評定問捲(GQOLI -74)評估治療前後的生活質量。結果治療前兩組 Y - BOCS 和GQOLI -74評分差異無統計學意義(P >0.05),治療4週後兩組 Y - BOCS 評分較治療前低,差異有統計學意義(P<0.05),治療8週後聯閤組評分較對照組降低更明顯,差異有統計學意義(P <0.05);治療12週後,聯閤組 GQOLI-74心理功能和社會功能評分高于對照組(P <0.05)。結論氟伏沙明聯閤思維阻斷療法治療有彊迫性思維的彊迫癥患者較單用氟伏沙明療效更好,併能改善患者的生活質量。
목적:탐토불복사명연합사유조단요법대강박증적료효。방법채용수궤수자표법장56례존재강박성사유병부합《국제질병분류(제10판)》(ICD -10)진단표준적강박증환자분위불복사명단일치료조화불복사명연합사유조단요법치료조,관찰12주。우치료전、치료제4、8、12주말채용야로포랑강박증상량표(Y - BOCS)진행평정,병채용생활질량종합평정문권(GQOLI -74)평고치료전후적생활질량。결과치료전량조 Y - BOCS 화GQOLI -74평분차이무통계학의의(P >0.05),치료4주후량조 Y - BOCS 평분교치료전저,차이유통계학의의(P<0.05),치료8주후연합조평분교대조조강저경명현,차이유통계학의의(P <0.05);치료12주후,연합조 GQOLI-74심리공능화사회공능평분고우대조조(P <0.05)。결론불복사명연합사유조단요법치료유강박성사유적강박증환자교단용불복사명료효경호,병능개선환자적생활질량。
Objective To observe the clinical efficacy of fluvoxamine combined with thinking prevention therapy on obsessive compulsive disorder. Methods A total of 56 patients with obsessive thinking and obsessive - compulsive disorder confirmed by ICD -10 diagnostic criteria were randomly divided into single fluvoxamine group and fluvoxamine combined with thinking prevention therapy group,and observed for 12 weeks. Yale - Brown Obsessive Compulsive Scale(Y - BOCS)was used to evaluate the mental status of subjects before treatment and the 4th ,8th ,12th week after the treatment. Meanwhile,the life quality of the subjects was evaluated by the Generic Life Quality Inventory(GQOLI - 74)at the same intervals. Results Before treatment,there was no statistically significant difference among Y - BOCS and GQOLI - 74 scores of the two groups(P > 0. 05). 4 weeks after treatment,Y - BOCS scores of the two groups was lower than those of before treatment,the difference was statistically significant(P < 0. 05). 8 weeks after treatment,the Y - BOCS score of the combined group decreased more than the control group,the difference was statistically significant(P < 0. 05). 12 weeks after treatment,the combined group psychological function and social function of GQOLI - 74 score were higher than that of control group(P < 0. 05). Conclusion Fluvoxamine combined with thinking prevention therapy has better efficacy than use fluvoxam-ine for patients with obsessive thinking and obsessive - compulsive disorder,and it can improve the patient′s quality of life.